Metabolic Vulnerabilities and Epigenetic Dysregulation in Myeloproliferative Neoplasms

The Janus kinase 2 (JAK2)-driven myeloproliferative neoplasms (MPNs) are associated with clonal myelopoiesis, elevated risk of death due to thrombotic complications, and transformation to acute myeloid leukemia (AML). JAK2 inhibitors improve the quality of life for MPN patients, but these approved t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Vasundhara, Wright, Kenneth L., Epling-Burnette, Pearlie K., Reuther, Gary W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734315/
https://www.ncbi.nlm.nih.gov/pubmed/33329600
http://dx.doi.org/10.3389/fimmu.2020.604142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734315/
https://www.ncbi.nlm.nih.gov/pubmed/33329600
http://dx.doi.org/10.3389/fimmu.2020.604142

Ejemplares similares